Not reported
Active06469424Private limited companyLondon
LUCANE PHARMA LIMITED
Significant control: Michael Van Woensel (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Lucane Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LUCANE PHARMA LIMITED is an active private limited company (company number 06469424) incorporated on 10 January 2008, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025 and cash of £26k, with 1 employee on average.
There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.
02
Ownership and control
- Michael Van Woensel
- owns 75–100% of shares
- holds 75–100% of voting rights
- Lucane Pharma Societe Par Actions Simplifee
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 10 January 200818 yrs ago
- Next accounts due
- 30 September 2027in 342 days
- Confirmation statement due
- 24 January 2027in 93 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£26k
+29%vs Dec 2024Not reported
1
No changevs Dec 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | — | £26k | — | — | — | — | 1 |
| 31 December 2024 | — | £20k | — | — | — | — | 1 |
Cash per employee£26kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Incorporated five or more years agoIncorporated 10 January 2008
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 342 days
- Confirmation statement duein 93 days
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in London
- SEAHORSE SCIENTIFIC SERVICES LTD.London · inc. Dec 2007
- MINA THERAPEUTICS LIMITEDLondon · inc. Mar 2008
- VERYAN HOLDINGS LIMITEDLondon · inc. Nov 2007
- NUFORMIX TECHNOLOGIES LIMITEDLondon · inc. Oct 2007
- UNITED BIOSOURCE HOLDING (UK) LIMITEDLondon · inc. Apr 2008
- AVACTA LIFE SCIENCES LIMITEDLondon · inc. May 2008
All companies incorporated on 10 January 2008 · in Jan 2008.
09
Reminders for LUCANE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.